首页> 外文期刊>European Journal of Pharmacology: An International Journal >Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis
【24h】

Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis

机译:巴比妥酸盐增强了特应性皮炎小鼠的瘙痒症 - 相关性皮炎:理解特应性皮炎中夜间瘙痒症的可能线索

获取原文
获取原文并翻译 | 示例
           

摘要

In chronic pruritic diseases such as atopic dermatitis, pruritus is exacerbated during nocturnal sleep; however, the underlying mechanism remains unclear. We previously demonstrated that acute administration of the sedative-hypnotics ethanol markedly enhanced itch-associated spontaneous scratching in a diet-induced mouse model of atopic dermatitis. In the present study, to expand our previous finding and provide a general mechanism for the central modulation of chronic itch, we examined whether other hypnotic drugs, such as barbiturates and benzodiazepines, also enhance scratching, and further investigated the underlying mechanism. Barbiturates markedly enhanced spontaneous scratching in the atopic dermatitis model but not controls. However, unexpectedly, benzodiazepines only slightly increased scratching, and the selective γ-aminobutyric acid type A (GABAA) receptor agonist, muscimol, had no effect. Local injection studies have demonstrated that barbiturates act at the supraspinal level to enhance scratching. Barbiturate-induced scratching was inhibited not only by GABAAreceptor antagonists but also by an L-type voltage-dependent calcium channel (L-VDCC) agonist and an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor agonist. An intracisternally injected AMPA receptor antagonist alone or in combination with an L-VDCC antagonist sufficiently enhanced scratching. Barbiturate-induced scratching enhancement was observed in another atopic dermatitis model, NC/Nga, but not in histamine-induced acute itch model in normal healthy mice. Overall, our results suggest that a synergistic effect among AMPA receptor inhibition, GABAAreceptor activation, and L-VDCC inhibition in the brain mediates barbiturate-induced scratching in atopic dermatitis mice. This observation may provide a novel clue to understanding a supraspinal itch mechanism in chronic diseases such as atopic dermatitis.
机译:在慢性瘙痒症如特应性皮炎,瘙痒在夜间睡眠期间加剧;但是,潜在机制仍然不清楚。我们以前证明镇静剂催眠乙醇的急性施用明显增强了饮食诱导的特应性皮炎的小鼠模型中的瘙痒型自发性刮伤。在本研究中,为了扩大我们之前的发现并提供慢性瘙痒的中枢调节的一般机制,我们检查了其他催眠药品,如巴比妥酸盐和苯并二氮杂虫,还增强划伤,并进一步调查了潜在机制。巴比妥酸盐显着增强了特征性皮炎模型的自发刮伤,但不能控制。然而,出乎意料的是,苯并二氮卓目前仅略微增加划伤,并且选择性γ-氨基丁酸型A(GABAA)受体激动剂,Muscrimol没有效果。局部注射研究表明,巴比妥酸盐在袋碱水平上起作用以增强划伤。不仅受到Gabaereceptor拮抗剂的抑制,还抑制了巴比妥酸盐诱导的刮擦,而且还被L型电压依赖性钙通道(L-VDCC)激动剂和α-氨基-3-羟基-5-甲基-4异恶唑(AMPA)抑制谷氨酸受体激动剂。单独或与L-VDCC拮抗剂的组合具有足够增强的划痕,单独注射AMPA受体拮抗剂。在另一个特征性皮炎模型中,NC / NGA观察到巴比妥酸盐诱导的耐刮擦增强,但不在正常健康小鼠中诱导的组胺诱导的急性痒模型。总体而言,我们的研究结果表明,脑中的AMPA受体抑制,GABA受体激活和L-VDCC抑制中的协同效应介导巴比妥酸盐诱导在特应性皮炎小鼠中刮伤。该观察结果可以提供新的线索,以了解慢性疾病(如特应性皮炎)中的脊椎瘙痒机制。

著录项

  • 来源
  • 作者单位

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

    Department of Pharmacology Division of Pathological Sciences Kyoto Pharmaceutical University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Atopic dermatitis; Barbiturate; Brain; Disease model; Itch; Sleep;

    机译:特应性皮炎;巴比妥酸盐;脑;疾病模型;痒;睡觉;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号